Presurgical 99mTc-sestamibi brain SPET/CT versus SPET: A comparison with MRI and histological data in 33 patients with brain tumours

Nuclear Medicine Communications

Volumn 30, Issue 9, 2009, Pages 660-668

  Cecchin, Diego ^a,c   Chondrogiannis, Sotirios ^a   Puppa, Alessandro Della ^a   Rotilio, Antonino ^a   Zustovich, Fable ^b   Manara, Renzo ^a   Gardiman, Marina ^a   Berti, Franco ^a   Zucchetta, Pietro ^a   Carollo, Carla ^a   Bui, Franco ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Brain neoplasms; Glioblastoma; Glioma; Magnetic resonance imaging I; Scintigraphy; Single photon emission tomography computed tomography; Technetium 99m sestamibi

Indexed keywords

GADOLINIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN REGION; BRAIN TUMOR; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROCEPHALUS; INTERMETHOD COMPARISON; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE PERIOD; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION;

ADULT; AGED; BRAIN; BRAIN NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REFERENCE STANDARDS; SCATTERING, RADIATION; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 68249156646     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32832ea9b7     Document Type: Article

References (30)

1. Le Jeune FP, Dubois F, Perez S, Blond S, Steinling M. Technetium-99m-sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results. Eur J Nucl Med Mol Imaging 2004; 31:714-719. (Pubitemid 38647911)
2. Perez SB, Le Jeune F, Dubois F, Steinling M. 99mTc-MIBI brain SPECT as an indicator of the chemotherapy response of recurrent, primary brain tumors. Nucl Med Commun 2007; 28:888-894. (Pubitemid 350306779)
3. 18F-FDG-PET in the clinical assessment of glioma recurrence. Eur J Nucl Med Mol Imaging 2008; 35:966-975
4. Alexiou GA, Fotopoulos AD, Papadopoulos A, Kyritsis AP, Polyzoidis KS, Tsiouris S. Evaluation of brain tumor recurrence by (99m)Tc-tetrofosmin SPECT: a prospective pilot study. Ann Nucl Med 2007; 21:293-298 (Pubitemid 350104527)
5. 99mTc-glucoheptonate SPECT for evaluation of recurrent brain tumours: a within-subject comparison with pathological correlation. J Clin Neurosci 2005; 12:27-31.
6. Utsunomiya K, Ballinger JR, Piquette-Miller M, Rauth AM, Tang W, Su ZF, et al. Comparison of the accumulation and efflux kinetics of technetium-99 m-sestamibi and technetium-99m tetrofosminin an MRP-expressing tumour cell line. Eur J Nucl Med 2000; 27:1786-1792.
7. 99mTc-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells. Cancer Biother Radiopharm 2005; 20:249-259.
8. Le Jeune FP, Dubois F, Blond S, Steinling M. Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies. J Neurooncol 2006; 77:177-183. (Pubitemid 44419753)
9. Beauchesne P, Pedeux R, Boniol M, Soler C. 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma. J Nucl Med 2004; 45:409-413. (Pubitemid 47618613)
10. Del Sole A, Moncayo R, Tafuni G, Lucignani G. Position of nuclear medicine techniques in the diagnostic work-up of brain tumors. Q J Nucl Med Mol Imaging 1994; 48:76-81.
11. 1H-MRS) to assess glioma recurrence after radiotherapy. Q J Nucl Med Mol Imaging 2006; 50:88-93.
12. Krengli M, Loi G, Sacchetti G, Manfredda I, Gambaro G, Brambilla M, et al. Delineation of target volume for radiotherapy of high-grade gliomas by (99 m)Tc-MIBI SPECT and MRI Fusion. Strahlenther Onkol 2007; 183:689-694. (Pubitemid 350175412)
13. Henze M, Ozdemir-Sahin N, Hipp P, Mier W, Eisenhut M, Debus J, et al. Comparison of diagnostic accuracy of (18)F-FDG PET, (123)I-IMT- and (99m)Tc-MIBI SPECT: evaluation of tumour progression in irradiated low grade astrocytomas. Nuklearmedizin 2006; 45:49-56.
14. 18F-FDG PET. Eur J Nucl Med Mol Imaging 2005; 32:52-59.
15. 18F-FDG. J Nucl Med 2005; 46:945-952.
16. Schillaci O, Filippi L, Manni C, Santoni R. Single-photon emission computed tomography/computed tomography in brain tumors. Semin Nucl Med 2007; 37:34-47. (Pubitemid 44854759)
17. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. Neuropathol Exp Neurol 2002; 61:215-225. (Pubitemid 34212595)
18. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114:97-109.
19. Sawyer LJ, Starritt HC, Hiscock SC, Evans MJ. Effective doses to patients from CT acquisitions on the GE Infinia Hawkeye: a comparison of calculation methods. Nucl Med Commun 2008; 29:144-149.
20. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals. ICRP publication 80. Ann ICRP 1998; 3:110.
21. Development Core Team. R: a Language and Environment for Statistical Computing. http://www.R-project.org 2008.
22. Keidar Z, Israel O, Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med 2003; 33:205-218. (Pubitemid 36859499)
23. Schillaci O, Simonetti G. Fusion imaging in nuclear medicine applications of dual-modality systems in oncology. Cancer Biother Radiopharm 2004; 19:1-10. (Pubitemid 38352280)
24. Reinders AA, Paans AM, de Jong BM, den Boer JA, Willemsen AT. Iterative versus filtered backprojection reconstruction for statistical parametric mapping of PET activation measurements: a comparative case study. Neuroimage 2002; 15:175-181
25. Chuang KS, Jan ML, Wu J, Lu JC, Chen S, Hsu CH, et al. A maximum likelihood expectation maximization algorithm with thresholding. Comput Med Imaging Graph 2005;29:571-578. (Pubitemid 41606730)
26. Baillet G, Albuquerque L, Chen Q, Poisson M, Delattre JY. Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 1994; 21: 1061-1066. (Pubitemid 24304431)
27. 99mTc-sestamibi. Nucl Med Commun 1995; 16:258-264.
28. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53:977-984. (Pubitemid 23087894)
29. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis (2-methoxyisobutylisonitrile) technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50:2198-2202. (Pubitemid 20115099)
30. Schneider JF, Confort-Gouny S, Viola A, Le Fur Y, Viout P, Bennathan M, et al. Multiparametric differentiation of posterior fossa tumors in children using diffusion-weighted imaging and short echo-time 1H-MR spectroscopy. J Magn Reson Imaging 2007; 26:1390-1398 (Pubitemid 350291264)